Browsing: Pharma

As biosimilar competition from Johnson & Johnson’s Stelara continues to weigh on sales, the long-awaited…

As artificial intelligence continues to rewrite the rules in countless industries, pharmaceutical companies are increasingly…

The FDA has reprimanded Pfizer over a Facebook ad for the cancer drug ADCETRIS, accusing…

The outcome of the third phase was negative, and from a seemingly tightening regulatory environment…

Eli Lilly has scored another victory in chronic lymphocytic leukemia (CLL) with the company’s BTK…

Regeneron is turning its attention to radiopharmaceuticals as the latest anti-obesity measures start to pay…

Most biopharmaceutical brands include more approved content than ever before. However, healthcare worker and patient…

Pharmacologists, drug development executives, and regulatory professionals face soaring costs, protracted timelines, and FDA hurdles. Discover 2026 trends in AI-driven drug discovery, biopharma manufacturing, clinical pipelines, and regulatory approvals to drive innovation.

Despite running into legal hurdles last month in his efforts to rebuild the U.S. vaccine…

Charles River Laboratories supports American Heart Association (AHA) campaigns and collaborates with nonprofit organizations on…